Victory Capital Management Inc. Sells 5,165 Shares of Mesa Laboratories, Inc. (NASDAQ:MLAB)

Victory Capital Management Inc. trimmed its stake in Mesa Laboratories, Inc. (NASDAQ:MLAB) by 36.9% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 8,836 shares of the medical instruments supplier’s stock after selling 5,165 shares during the period. Victory Capital Management Inc.’s holdings in Mesa Laboratories were worth $1,165,000 at the end of the most recent quarter.

Other large investors have also recently made changes to their positions in the company. Smartleaf Asset Management LLC grew its stake in Mesa Laboratories by 62.0% during the 4th quarter. Smartleaf Asset Management LLC now owns 1,844 shares of the medical instruments supplier’s stock worth $243,000 after buying an additional 706 shares during the last quarter. Los Angeles Capital Management LLC lifted its holdings in shares of Mesa Laboratories by 3.0% in the 4th quarter. Los Angeles Capital Management LLC now owns 3,394 shares of the medical instruments supplier’s stock valued at $448,000 after buying an additional 100 shares during the period. Rice Hall James & Associates LLC lifted its holdings in shares of Mesa Laboratories by 25.1% in the 4th quarter. Rice Hall James & Associates LLC now owns 27,668 shares of the medical instruments supplier’s stock valued at $3,649,000 after buying an additional 5,560 shares during the period. Principal Financial Group Inc. boosted its position in Mesa Laboratories by 9.3% during the fourth quarter. Principal Financial Group Inc. now owns 38,359 shares of the medical instruments supplier’s stock worth $5,058,000 after purchasing an additional 3,252 shares in the last quarter. Finally, Choreo LLC boosted its position in Mesa Laboratories by 38.0% during the fourth quarter. Choreo LLC now owns 5,052 shares of the medical instruments supplier’s stock worth $667,000 after purchasing an additional 1,392 shares in the last quarter. 90.60% of the stock is owned by institutional investors.

Mesa Laboratories Stock Performance

NASDAQ MLAB opened at $124.24 on Thursday. The company has a market cap of $675.12 million, a PE ratio of -2.69 and a beta of 0.82. The stock’s 50 day simple moving average is $138.46 and its 200-day simple moving average is $129.19. Mesa Laboratories, Inc. has a 1-year low of $83.68 and a 1-year high of $155.12. The company has a debt-to-equity ratio of 0.61, a current ratio of 0.71 and a quick ratio of 0.53.

Mesa Laboratories (NASDAQ:MLAB) last announced its quarterly earnings data on Tuesday, February 4th. The medical instruments supplier reported $2.07 EPS for the quarter, topping analysts’ consensus estimates of $1.41 by $0.66. Mesa Laboratories had a positive return on equity of 30.23% and a negative net margin of 104.92%. As a group, equities research analysts anticipate that Mesa Laboratories, Inc. will post 8 EPS for the current fiscal year.

Mesa Laboratories Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, March 17th. Shareholders of record on Friday, February 28th were paid a dividend of $0.16 per share. The ex-dividend date of this dividend was Friday, February 28th. This represents a $0.64 annualized dividend and a yield of 0.52%. Mesa Laboratories’s dividend payout ratio (DPR) is -1.38%.

Mesa Laboratories Company Profile

Mesa Laboratories, Inc develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries.